The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868
Incidence of Parkinson's Disease: Variation by Age, Gender, and Race/Ethnicity
Van Den Eeden, S. K. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg068 · Cited by 1,747
Neuropathology of Parkinsonʼs Disease
Forno, L. S. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199603000-00001 · Cited by 1,465
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183
Molecular mechanisms of quinone cytotoxicity
O'Brien, P. J. (1991) · Chemico-Biological Interactions · doi:10.1016/0009-2797(91)90029-7 · Cited by 1,029
Description of Parkinson's Disease as a Clinical Syndrome
FAHN, S. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07458.x · Cited by 977
Tikka, T., Fiebich, B. L., Goldsteins, G., Keinänen, R., & Koistinaho, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02580.2001 · Cited by 958
Microglial activation and dopamine terminal loss in early Parkinson's disease
Ouchi, Y., Yoshikawa, E., Sekine, Y., Futatsubashi, M., Kanno, T., Ogusu, T., & Torizuka, T. (2005) · Annals of Neurology · doi:10.1002/ana.20338 · Cited by 843
McCormack, A. L., Thiruchelvam, M., Manning-Bog, A. B., Thiffault, C., Langston, J. W., Cory-Slechta, D. A., & Di Monte, D. A. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0507 · Cited by 838
Self-citationBabior, B. M. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2003.12.001 · Cited by 705
Kitazawa, M., Oddo, S., Yamasaki, T. R., Green, K. N., & LaFerla, F. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2868-05.2005 · Cited by 697
The Herbicide Paraquat Causes Up-regulation and Aggregation of α-Synuclein in Mice
Manning-Bog, A. B., McCormack, A. L., Li, J., Uversky, V. N., Fink, A. L., & Di Monte, D. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100560200 · Cited by 684
Self-citationNonsteroidal Anti-inflammatory Drugs and the Risk of Parkinson Disease
Chen, H., Zhang, S. M., Hernán, M. A., Schwarzschild, M. A., Willett, W. C., Colditz, G. A., Speizer, F. E., & Ascherio, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1059 · Cited by 634
Wu, D.-C., Teismann, P., Tieu, K., Vila, M., Jackson-Lewis, V., Ischiropoulos, H., & Przedborski, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0937239100 · Cited by 633
Inflammation and neurodegeneration in Parkinson's disease
McGeer, P. L., & McGeer, E. G. (2004) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.01.005 · Cited by 625
Paraquat: model for oxidant-initiated toxicity.
Bus, J. S., & Gibson, J. E. (1984) · Environmental Health Perspectives · doi:10.1289/ehp.845537 · Cited by 593
E PIDEMIOLOGY OF N EURODEGENERATION
Mayeux, R. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.043002.094919 · Cited by 515
Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease
Chen, H., Jacobs, E., Schwarzschild, M. A., McCullough, M. L., Calle, E. E., Thun, M. J., & Ascherio, A. (2005) · Annals of Neurology · doi:10.1002/ana.20682 · Cited by 472
Monte, D. A. D. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00501-5 · Cited by 361
Critical Role for Microglial NADPH Oxidase in Rotenone-Induced Degeneration of Dopaminergic Neurons
Gao, H.-M., Liu, B., & Hong, J.-S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-15-06181.2003 · Cited by 337
Selective microglial activation in the rat rotenone model of Parkinson's disease
Sherer, T. B., Betarbet, R., Kim, J.-H., & Greenamyre, J. T. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00172-1 · Cited by 316
Thiruchelvam, M., McCormack, A., Richfield, E. K., Baggs, R. B., Tank, A. W., Di Monte, D. A., & Cory‐Slechta, D. A. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02781.x · Cited by 280
Self-citationRole of oxidative stress in paraquat‐induced dopaminergic cell degeneration
McCormack, A. L., Atienza, J. G., Johnston, L. C., Andersen, J. K., Vu, S., & Di Monte, D. A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03088.x · Cited by 278
Self-citationPeng, J., Mao, X. O., Stevenson, F. F., Hsu, M., & Andersen, J. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404596200 · Cited by 233
A mechanism of paraquat toxicity involving nitric oxide synthase
Day, B. J., Patel, M., Calavetta, L., Chang, L.-Y., & Stamler, J. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12760 · Cited by 206
van Ogtrop, M. L., Andes, D., Stamstad, T. J., Conklin, B., Weiss, W. J., Craig, W. A., & Vesga, O. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.943-949.2000 · Cited by 179
Redox cycling of the herbicide paraquat in microglial cultures
Bonneh-Barkay, D., Reaney, S. H., Langston, W. J., & Di Monte, D. A. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.11.005 · Cited by 169
Self-citationGao, H., Liu, B., Zhang, W., & Hong, J. (2003) · The FASEB Journal · doi:10.1096/fj.03-0203fje · Cited by 150
Rotenone potentiates dopamine neuron loss in animals exposed to lipopolysaccharide prenatally
Ling, Z., Chang, Q. A., Tong, C. W., Leurgans, S. E., Lipton, J. W., & Carvey, P. M. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.08.006 · Cited by 132
Clejan, L. A., & Cederbaum, A. I. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90412-7 · Cited by 90
Frank, D. M., Arora, P. K., Blumer, J. L., & Sayre, L. M. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(87)80183-3 · Cited by 74
McCormack, A. L., Atienza, J. G., Langston, J. W., & Monte, D. A. D. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.03.069 · Cited by 69
Self-citationTemporal effects of paraquat/maneb on microglial activation and dopamine neuronal loss in older rats
Saint‐Pierre, M., Tremblay, M., Attila Gabor, S. I. K., Gross, R. E., & Cicchetti, F. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03923.x · Cited by 62
Langston, J. W., Forno, L. S., Tetrud, J., Reeves, A. G., Kaplan, J. A., & Karluk, D. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199910)46:4 · Cited by 1
Cited by
Chin-Chan, M., Navarro-Yepes, J., & Quintanilla-Vega, B. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00124 · Cited by 707
Tansey, M. G., McCoy, M. K., & Frank-Cannon, T. C. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.07.004 · Cited by 583
Neurotoxin-based models of Parkinson's disease
Bové, J., & Perier, C. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2011.10.057 · Cited by 506
Mitochondria Are a Major Source of Paraquat-induced Reactive Oxygen Species Production in the Brain
Castello, P. R., Drechsel, D. A., & Patel, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700827200 · Cited by 477
Cell Death Mechanisms and Their Implications in Toxicology
Orrenius, S., Nicotera, P., & Zhivotovsky, B. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfq268 · Cited by 411
Metadata
- Authors
- Purisai, M. G., McCormack, A. L., Cumine, S., Li, J., Isla, M. Z., & Di Monte, D. A.
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2007-02
- Volume
- 25
- Issue
- 2
- Pages
- 392-400
- ISSN
- 0969-9961 (ISSN-L)
- OpenAlex
- W2052770514
- Cited by
- 254
- References
- 34
- FWCI
- 8.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.